Skip to main content

Table 2 Associations between gene methylation and the CRC risk in GEO dataset

From: Inhibitory immune checkpoints PDCD-1 and LAG-3 hypermethylation may reduce the risk of colorectal cancer

Gene

Hypomethylation

Hypermethylation

OR (95%CI)

*P value

ORadj (95%CI)

*P value

PDCD-1 (cg06291111)

 CRCs (n = 166), n%

142 (85.54%)

24 (14.46%)

 

 < 0.0001

 

 < 0.0001

 Controls (n = 424), n%

267 (62.97%)

157 (37.03%)

0.287 (0.179–0.462)

 

0.322 (0.197–0.528)

 

LAG-3 (cg10191002)

 CRCs (n = 166), n%

66 (39.76%)

100 (60.24%)

 

0.004

 

0.048

 Controls (n = 424), n%

116 (27.36%)

308 (72.64%)

0.571 (0.391–0.832)

 

0.666 (0.446–0.996)

 
  1. CRC, colorectal cancer; CI confidence interval; OR odds ratio; ORadj, adjusted for age, gender
  2. *P values < 0.05 were considered statistically significant  and were indicated in boldÂ